Corporations
Munich Re to do share buyback
Due to net income decline, the world's biggest reinsurer Munich Re would do a share buyback program to be completed by April 30, 2014.
ImmunGene Inc raises USD9 million in Series A round
USD9 million was raised in Series A funding round for ImmunGene Inc. Biotechnology company ImmunGene Inc. is focused on the development of anti-body cytokine fusion technology therapy for oncological applications.
BestInvest acquired by a portfolio firm of Permira Funds
A Permira Funds portfolio company had purchased BestInvest for an undisclosed amount. UK wealth management and online investment service firm BestInvest announced it had agreed to be acquired by a portfolio company of Permira funds.
Apple patent filing indicates how future iWatch works - report
Should Apple Inc's patent technology for its potential iWatch be successful, RBC capital markets analyst Amit Daryanani said revenue coming from the iWatch could add another USD9 billion to the tech giant's revenues.